Shortly after COVID-19 entered our collective lexicon, investments began pouring into the health care industry. The warts on the U.S. health care system that COVID-19 exposed were enough for lenders, backers and buyers to continue to throw money at the companies – or even ideas – that could cover up or eradicate those warts. Home-based […]
By continuing to use the site, you agree to the use of cookies. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy
